Physician profile
Lawrence W Krieger
NPI 1619951845
$2,065.72
in general payments reported to CMS, 2019-2025
15 companies · $438 in 2025
The $438 reported for 2025 was less than what a typical Otolaryngic Allergy provider received nationally (typical 2025 total: $449).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $163 · 2021: $140 · 2022: $482 · 2023: $344 · 2024: $293 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,074.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $411.62 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $360.00 | 2019-2025 | Dupixent |
| Genzyme Corporation | $340.12 | 2021-2025 | |
| Alk-Abello, INC | $335.89 | 2019-2023 | Odactra, Ragwitek, Grastek |
| Optinose US, INC. | $123.29 | 2019-2025 | |
| Acclarent, INC | $119.95 | 2020-2024 | Acclarent Aera |
| Smith+Nephew, INC. | $88.89 | 2019-2025 | Halo, Tula, Coblation |
| Aerin Medical INC. | $54.64 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $51.59 | 2023-2024 | Bridion |
| Neurent Medical Limited | $48.15 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Stryker Corporation | $37.63 | 2019 | |
| Medtronic, INC. | $34.00 | 2024-2025 | Propel, Stealthstation S8 Platform |
| Paratek Pharmaceuticals, INC. | $25.35 | 2025 | Xhance |
| Ars Pharmaceuticals Operations, INC. | $17.86 | 2025 | Neffy |
| Kaleo, INC. | $16.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Krieger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.